Feed Additives Manufacturing Plant in Chahade and Therapeutics/Formulations Manufacturing Unit in Vevoor (Palghar, Maharashtra)
Poultry Federation of India (PFI) team recently visited our state of the art “Feed Additives Manufacturing Facilities in Chahade” and “Therapeutics/Formulations Manufacturing Unit in Vevoor (Palghar, Maharashtra)” of Stallen South Asia Pvt. Ltd. in Palghar, Maharashtra.
The visit was aimed at gaining deeper insights into modern practices in animal health and nutrition. The distinguished delegation comprised Mr. Ranpal (Bittu) Dhanda, President, Mr. Sanjeev Gupta, Vice President (HQ) and Mr. Ricky Thaper, Joint Secretary, Poultry Federation of India. They were warmly welcomed by the leadership team at Stallen and taken through the facility’s operations, manufacturing processes and innovation-driven initiatives.
“Stallen’s Feed additives and supplement manufacturing facilities in Chahade” is recognized for its world-class infrastructure and manufacturing excellence. It specializes in a broad portfolio of feed additives and supplements for poultry and cattle, including antibacterial solutions, treatments targeting mycoplasmal infections, deworming agents, performance enhancers, anthelmintics, mineral supplements, toxin-binding formulations, antidiarrheals, growth promoters, anticoccidials, water sanitation products, fly control solutions, and disinfectants. These products are meticulously crafted and made available in various convenient forms such as tablets, boluses, powders, oral liquid solutions. The manufacturing unit is equipped with advanced machinery for formulation, granulation, liquid filling, and packaging. Rigorous quality control is implemented at every stage, from raw material testing to final product release, ensuring product consistency, safety, and compliance with global standards.
Another dedicated “Therapeutics/Formulations Manufacturing Unit in Vevoor (Palghar, Maharashtra)” is a crucial facility for manufacturing pharmaceutical products that range between regular therapeutic drugs as well as beta-lactam formulations. This formulation unit is equipped with state-of-the-art facilities and machinery required for the formulation and production of pharmaceutical products. This includes equipment for mixing, blending, granulation, drying, and packaging. The capacities are built for effervescent tablets, liquid form (oral and topical), oral powder, bolus and ointment. The facilities comply with Good Manufacturing Practices (GMP) and are aligned with regulatory requirements to serve both domestic and international markets. With their company products registered in over 65 countries, this milestone reinforces India’s pursuit of veterinary self-sufficiency and innovation-led growth.
During the visit the delegation had good interaction with Stallen’s senior leadership, including Mr. Aniket Parikh (Director), Dr. Sanjay Singhal (Chief Operating Officer- Poultry & Cattle) and Mr. Davinder Kumar (Vice President -Sales, North & Central).
Mr. Aniket Parikh, Director, Stallen South Asia Pvt. Ltd., told that Stallen company was started by his visionary father Late Shri AB Parikh in the year 1992. He added that Stallen products are now being exported to over 65 countries in North America, South America, Europe, Middle East, China, Japan, South East Asia and Australia. Mr. Davinder Kumar, Vice President Sales (North & Central) highlighted about their tie-up with FATRO, Italy and their company is marketing the entire vaccine range of FATRO in India Subcontinent. Dr. Sanjay Singhal, Chief Operating Officer (Poultry & Cattle) added that Stallen’s Pharmaceutical third unit which focus on Halquinol 98%, a non-antibiotic growth promoter being manufactured as per BP 80 (British Pharmacopoeia 1980) standards in Vatva, Gujarat. The delegation appreciated Stallen’s warm hospitality, operational transparency and unwavering commitment to quality. The visit reaffirmed the vital role of companies like Stallen in driving progress within India’s veterinary landscape through innovation, regulatory excellence, and responsible manufacturing.